FindMyKOL
Clinical trialNCT04822753CompletedInterventional

Platelet Rich Plasma (PRP) for Facet Mediated Lumbar Low Back Pain

NCT04822753 is an interventional trial sponsored by Womack Army Medical Center. As of 21 Nov 2026, it is completed. It studies Facet Joint Pain; Low Back Pain. The registry lists an enrollment of 91 participants at 1 site in 1 country. The registry lists a start date of 29 Sept 2021 and a primary completion date of 23 Jun 2025.

SponsorWomack Army Medical Center →Enrollment91Facet Joint Pain; Low Back Pain
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT04822753
FieldValue
Registry IDNCT04822753
StatusCompleted
Study typeInterventional trial
Lead sponsorWomack Army Medical Center
Enrollment91
Registered sites1
Countries1
ConditionsFacet Joint Pain; Low Back Pain
Start29 Sept 2021
Primary completion23 Jun 2025
Study completion23 Jun 2025
Last update posted11 Jul 2025

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Low back pain (LBP) is both the single most common cause of disability and the leading cause of visits when military personnel go to their primary care doctors. Military personnel that deal with LBP can often be placed on limited duty profile. Not surprisingly, the direct and indirect costs of low back and neck pain accounts for approximately $88 billion of health care expenditure. In order to reduce the large financial and personal cost, clinical studies must be designed to treat LBP. This study will provide evidence-based medicine on a new regenerative medicine treatment option that may significantly affect military personnel with LBP. PRP (Platelet Rich Plasma) may offer alternate treatment methods that may help preserve the facet joint structures, and improve pain and function without causing destructive lesions or worsening degenerative joints. This healing process may favor improved participation with rehabilitation therapy and ultimately improve return to duty status. This study will also assess the effectiveness of point of care generated PRP, as a minimally invasive treatment option for treating lumbar facet pain. Specifically, PRP effectiveness will be compared to injecting placebo control when injected into facet joints.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

North Carolina, United States1 site
  • Womack Army Medical Center

    Fort Liberty

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth Carolina: 1 siteNC1South CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT04822753

Each answer restates registry values shown on this page.

What is NCT04822753?

NCT04822753 is an interventional trial sponsored by Womack Army Medical Center. It studies Facet Joint Pain; Low Back Pain.

Who leads NCT04822753?

The registry names Min Ho Chang, MD (principal investigator, Womack Army Medical Center) as the overall official.

Where does NCT04822753 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT04822753 end?

The registry lists a primary completion date of 23 Jun 2025 and a study completion date of 23 Jun 2025. The sponsor last updated the record on 11 Jul 2025.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.